FDG-PET imaging in the management of non-small-cell lung cancer

被引：9
|
作者：
Salminen, E
Mac Manus, M
机构：
[1] Turku Univ Hosp, Dept Radiotherapy & Oncol, FIN-20520 Turku, Finland
[2] Peter MacCallum Canc Inst, Melbourne, Vic 3000, Australia
来源：
ANNALS OF ONCOLOGY | 2002年 / 13卷 / 03期
关键词：
FDG-PET; non-small-cell lung cancer; outcome; staging; treatment;
D O I：
10.1093/annonc/mdf106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Lung cancer is currently the leading cause of cancer-related death in both men and women in most Western countries. Tumour stage is the strongest prognostic factor and the most important parameter guiding treatment decision making. Metabolic positron emission tomography imaging with fluorodeoxyglucose (FDG-PET) has consistently proved superior to conventional imaging for staging of non-small-cell lung cancer and provides information of greater prognostic significance than can be obtained using conventional approaches. FDG-PET has been approved in the USA. Germany and the UK as a basic and invaluable tool in the management of lung cancer.
引用
收藏
页码：357 / 360
页数：4
相关论文
共 50 条
  • [41] Cavitary lung cancer and FDG-PET
    Triponez, F
    de Perrot, M
    Orrit, J
    Robert, J
    Spiliopoulos, A
    ANNALES DE CHIRURGIE, 2002, 127 (05): : 403 - 404
  • [42] Molecular imaging of hypoxia in non-small-cell lung cancer
    Yip, Connie
    Blower, Philip J.
    Goh, Vicky
    Landau, David B.
    Cook, Gary J. R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (06) : 956 - 976
  • [43] Molecular imaging of hypoxia in non-small-cell lung cancer
    Connie Yip
    Philip J. Blower
    Vicky Goh
    David B. Landau
    Gary J. R. Cook
    European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42 : 956 - 976
  • [44] FDG-PET imaging in duodenal cancer
    Naoto Watanabe
    Shinichi Hayashi
    Hiroshi Kato
    Masashi Shimizu
    Yuichi Kamisaki
    Kyo Noguchi
    Mika Kishida
    Ichiro Matsunari
    Kinichi Hisada
    Hikaru Seto
    Annals of Nuclear Medicine, 2004, 18 : 351 - 353
  • [45] Investigating the histopathologic correlates of 18F-FDG PET heterogeneity in non-small-cell lung cancer
    Bashir, Usman
    Foot, Oliver
    Wise, Olga
    Siddique, Muhammad M.
    Mclean, Emma
    Bille, Andrea
    Goh, Vicky
    Cook, Gary J.
    NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (12) : 1197 - 1206
  • [46] Diagnostic and staging impact of radiotherapy planning FDG-PET-CT in non-small-cell lung cancer
    Lin, Peter
    Koh, Eng-Siew
    Lin, Michael
    Vinod, Shalini K.
    Ho-Shon, Ivan
    Yap, June
    Som, Seu
    RADIOTHERAPY AND ONCOLOGY, 2011, 101 (02) : 284 - 290
  • [47] Diagnosis efficacy of structural (CT) and functional (FDG-PET) imaging methods in the thoracic and extrathoracic staging of non-small cell lung cancer
    Antonio Rodríguez Fernández
    Manuel Gómez Río
    José Manuel Llamas Elvira
    Abel Sánchez-Palencia Ramos
    María Bellón Guardia
    Carlos Ramos Font
    Pablo Torné Poyatos
    Vicente Pedraza Muriel
    Clinical and Translational Oncology, 2007, 9 : 32 - 39
  • [48] FDG-PET/CT imaging for tumor staging and definition of tumor volumes in radiation treatment planning in non-small cell lung cancer
    Zheng, Yuanda
    Sun, Xiaojiang
    Wang, Jian
    Zhang, Lingnan
    Di, Xiaoyun
    Xu, Yaping
    ONCOLOGY LETTERS, 2014, 7 (04) : 1015 - 1020
  • [49] FDG-PET imaging in duodenal cancer
    Watanabe, N
    Hayashi, S
    Kato, H
    Shimizu, M
    Kamisaki, Y
    Noguchi, K
    Kishida, M
    Matsunari, I
    Hisada, K
    Seto, H
    ANNALS OF NUCLEAR MEDICINE, 2004, 18 (04) : 351 - 353
  • [50] Combining PD-L1 Expression and Standardized Uptake Values in FDG-PET/CT Can Predict Prognosis in Patients With Resectable Non-Small-Cell Lung Cancer
    Miyazawa, Tomoyuki
    Otsubo, Kanji
    Sakai, Hiroki
    Kimura, Hiroyuki
    Chosokabe, Motohiro
    Morikawa, Kei
    Furuya, Naoki
    Marushima, Hideki
    Kojima, Koji
    Mineshita, Masamichi
    Koike, Junki
    Saji, Hisashi
    CANCER CONTROL, 2021, 28
12345